<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05060367</url>
  </required_header>
  <id_info>
    <org_study_id>2021-527</org_study_id>
    <nct_id>NCT05060367</nct_id>
  </id_info>
  <brief_title>Pharmacokinetic Analysis of Nutrient Absorption From a Novel Liposomal Multivitamin/Mineral Formulation</brief_title>
  <official_title>Pharmacokinetic Analysis of Nutrient Absorption From a Novel Liposomal Multivitamin/Mineral Formulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Tech University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nutraceutical Corporation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Texas Tech University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project is a randomized crossover trial examining the pharmacokinetic profiles of&#xD;
      standard and liposomal multivitamin/mineral (MVM) formulations in healthy adults. Each&#xD;
      participant will complete two research visits, which will be identical except for which MVM&#xD;
      product is consumed. At each visit, participants will report to the laboratory after an&#xD;
      overnight fast. After a baseline blood sample is collected, the MVM product will be consumed&#xD;
      alongside a standardized breakfast. At 2-, 4-, and 6-hours post-ingestion, additional blood&#xD;
      samples will be collected. Concentrations of representative fat-soluble and water-soluble&#xD;
      vitamins, as well as representative minerals, will be analyzed to determine whether&#xD;
      differential nutrient absorption is observed with the liposomal MVM as compared to the&#xD;
      standard MVM product. The results of this study will provide information about a novel&#xD;
      liposomal MVM formulation and will inform future research and commercial applications of this&#xD;
      technology.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 16, 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vitamin D</measure>
    <time_frame>The AUC value will be calculated using data from four time points: immediately prior to multivitamin/mineral ingestion and 2, 4, and 6 hours after ingestion of multivitamin/mineral.</time_frame>
    <description>Area under the concentration vs. time curve (AUC) for vitamin D2/D3 in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vitamin D</measure>
    <time_frame>The Cmax value will be determined as the highest concentration observed from four time points: immediately prior to multivitamin/mineral ingestion and 2, 4, and 6 hours after ingestion of multivitamin/mineral.</time_frame>
    <description>Maximal concentration (Cmax) of vitamin D2/D3 in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vitamin A</measure>
    <time_frame>The AUC value will be calculated using data from four time points: immediately prior to multivitamin/mineral ingestion and 2, 4, and 6 hours after ingestion of multivitamin/mineral.</time_frame>
    <description>Area under the concentration vs. time curve (AUC) for vitamin A in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vitamin A</measure>
    <time_frame>The Cmax value will be determined as the highest concentration observed from four time points: immediately prior to multivitamin/mineral ingestion and 2, 4, and 6 hours after ingestion of multivitamin/mineral.</time_frame>
    <description>Maximal concentration (Cmax) of vitamin A in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vitamin E</measure>
    <time_frame>The AUC value will be calculated using data from four time points: immediately prior to multivitamin/mineral ingestion and 2, 4, and 6 hours after ingestion of multivitamin/mineral.</time_frame>
    <description>Area under the concentration vs. time curve (AUC) for vitamin E in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vitamin E</measure>
    <time_frame>The Cmax value will be determined as the highest concentration observed from four time points: immediately prior to multivitamin/mineral ingestion and 2, 4, and 6 hours after ingestion of multivitamin/mineral.</time_frame>
    <description>Maximal concentration (Cmax) of vitamin E in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vitamin B12</measure>
    <time_frame>The AUC value will be calculated using data from four time points: immediately prior to multivitamin/mineral ingestion and 2, 4, and 6 hours after ingestion of multivitamin/mineral.</time_frame>
    <description>Area under the concentration vs. time curve (AUC) for vitamin B12 in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vitamin B12</measure>
    <time_frame>The Cmax value will be determined as the highest concentration observed from four time points: immediately prior to multivitamin/mineral ingestion and 2, 4, and 6 hours after ingestion of multivitamin/mineral.</time_frame>
    <description>Maximal concentration (Cmax) of vitamin B12 in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vitamin B9 (folic acid)</measure>
    <time_frame>The AUC value will be calculated using data from four time points: immediately prior to multivitamin/mineral ingestion and 2, 4, and 6 hours after ingestion of multivitamin/mineral.</time_frame>
    <description>Area under the concentration vs. time curve (AUC) for vitamin B9 (folic acid) in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vitamin B9 (folic acid)</measure>
    <time_frame>The Cmax value will be determined as the highest concentration observed from four time points: immediately prior to multivitamin/mineral ingestion and 2, 4, and 6 hours after ingestion of multivitamin/mineral.</time_frame>
    <description>Maximal concentration (Cmax) of vitamin B9 (folic acid) in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vitamin C</measure>
    <time_frame>The AUC value will be calculated using data from four time points: immediately prior to multivitamin/mineral ingestion and 2, 4, and 6 hours after ingestion of multivitamin/mineral.</time_frame>
    <description>Area under the concentration vs. time curve (AUC) for vitamin C in plasma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vitamin C</measure>
    <time_frame>The Cmax value will be determined as the highest concentration observed from four time points: immediately prior to multivitamin/mineral ingestion and 2, 4, and 6 hours after ingestion of multivitamin/mineral.</time_frame>
    <description>Maximal concentration (Cmax) of vitamin C in plasma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Magnesium</measure>
    <time_frame>The AUC value will be calculated using data from four time points: immediately prior to multivitamin/mineral ingestion and 2, 4, and 6 hours after ingestion of multivitamin/mineral.</time_frame>
    <description>Area under the concentration vs. time curve (AUC) for magnesium in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Magnesium</measure>
    <time_frame>The Cmax value will be determined as the highest concentration observed from four time points: immediately prior to multivitamin/mineral ingestion and 2, 4, and 6 hours after ingestion of multivitamin/mineral.</time_frame>
    <description>Maximal concentration (Cmax) of magnesium in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Iron</measure>
    <time_frame>The AUC value will be calculated using data from four time points: immediately prior to multivitamin/mineral ingestion and 2, 4, and 6 hours after ingestion of multivitamin/mineral.</time_frame>
    <description>Area under the concentration vs. time curve (AUC) for iron in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Iron</measure>
    <time_frame>The Cmax value will be determined as the highest concentration observed from four time points: immediately prior to multivitamin/mineral ingestion and 2, 4, and 6 hours after ingestion of multivitamin/mineral.</time_frame>
    <description>Maximal concentration (Cmax) of iron in serum</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Vitamin Absorption</condition>
  <condition>Mineral Absorption</condition>
  <arm_group>
    <arm_group_label>Liposomal multivitamin/mineral condition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ingestion of novel, liposomal multivitamin/mineral.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard multivitamin/mineral condition</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ingestion of standard multivitamin/mineral.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Liposomal multivitamin/mineral</intervention_name>
    <description>Two-capsule dose of liposomal multivitamin/mineral that is nutrient-matched to the standard multivitamin/mineral.</description>
    <arm_group_label>Liposomal multivitamin/mineral condition</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Standard multivitamin/mineral</intervention_name>
    <description>Two-capsule dose of standard multivitamin/mineral that is nutrient-matched to the liposomal multivitamin/mineral.</description>
    <arm_group_label>Standard multivitamin/mineral condition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. age 18 to 65 at time of consent&#xD;
&#xD;
          2. ability to comply with study procedures&#xD;
&#xD;
          3. availability to complete study based on durations of individual visits and scheduling&#xD;
             requirements&#xD;
&#xD;
          4. body mass of at least 110 pounds&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. failure to meet any of the aforementioned inclusion criteria&#xD;
&#xD;
          2. presence of a disease or medical condition that could reasonably influence study&#xD;
             outcomes or make participation inadvisable&#xD;
&#xD;
          3. use of medication that could reasonably influence study outcomes or make participation&#xD;
             inadvisable&#xD;
&#xD;
          4. inability to abstain from medication, supplement, or substance use during the&#xD;
             overnight fast and duration of the study visit&#xD;
&#xD;
          5. anticipated inability to provide blood samples (e.g., known difficulty providing blood&#xD;
             samples)&#xD;
&#xD;
          6. currently pregnant or breastfeeding, based on self-report&#xD;
&#xD;
          7. allergy that would prevent safe consumption of standardized breakfast or multivitamin&#xD;
             product&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Grant M Tinsley, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Tech University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Grant M Tinsley, PhD</last_name>
    <phone>8068345895</phone>
    <email>grant.tinsley@ttu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Kinesiology &amp; Sport Management</name>
      <address>
        <city>Lubbock</city>
        <state>Texas</state>
        <zip>79409</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grant M Tinsley, PhD</last_name>
      <phone>806-834-5895</phone>
      <email>grant.tinsley@ttu.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 10, 2021</study_first_submitted>
  <study_first_submitted_qc>September 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 29, 2021</study_first_posted>
  <last_update_submitted>September 17, 2021</last_update_submitted>
  <last_update_submitted_qc>September 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

